SEARCH
Home
News
Fortune 500
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Great Place to Work
Tech
AI
Innovation
Cybersecurity
Finance
Personal Finance
Real Estate
Economy
Investing
Banking
Crypto
Leadership
Success
Future of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Analytics
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Home
News
FORTUNE 500
FORTUNE 500
FORTUNE SEA 500
Fortune 500 Europe
Fortune Global 500
Fortune China 500
Great Place to Work
Tech
Tech
AI
Innovation
Cybersecurity
Finance
Finance
Personal Finance
Real Estate
Economy
Banking
Investing
Crypto
Leadership
Leadership
Success
Future of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Rankings
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Asia
Europe
Analytics
Sy Mukherjee
Sy Mukherjee is a former health care reporter for
Fortune.
Page 34 of 100
Health
The Ideal Diet That Doesn’t Exist: Brainstorm Health
By
Sy Mukherjee
Health
Help Us Find the Companies Changing the World: Brainstorm Health
By
Sy Mukherjee
Health
The Ethics of ‘Biohacking’ and Digital Health Data: Brainstorm Health
By
Sy Mukherjee
Health
Digital Bike Maker Peloton’s Confidential-ish IPO: Brainstorm Health
By
Sy Mukherjee
Health
A Holdout on the CVS-Aetna Deal: Brainstorm Health
By
Sy Mukherjee
Health
The World’s Largest Cancer Conference: Brainstorm Health
By
Sy Mukherjee
Health
Grail Touts Its Blood Test for Detecting Cancer Early: Brainstorm Health
By
Sy Mukherjee
Health
From Pokemon Go to… Pokemon Sleep?—Brainstorm Health
By
Sy Mukherjee
Health
Brainstorm Health: Amarin Stock, Oklahoma Opioid Testimony, Work Burnout
By
Sy Mukherjee
Commentary
How This Biotech Wants to Become a Stem Cell Therapy Success Story
By
Sy Mukherjee
Health
Brainstorm Health: Athersys Stem Cell Treatment, Alexa in Medicine, Oklahoma Opioid Suit
By
Sy Mukherjee
Health
Brainstorm Health: Novartis $2.1 Million Drug, Brexit Fallout, Jakafi Drug Approval
By
Sy Mukherjee
Health
Brainstorm Health: Heart Disease, Amazon Emotion Detection, JPMorgan and Purdue
By
Sy Mukherjee
Health
Brainstorm Health: CRISPR V. Superbugs, Gottlieb to NEA, UniQure Gene Therapy
By
Sy Mukherjee
Health
Brainstorm Health: Verily Pharma Partners, ‘Conscience’ Clause Lawsuits, Merck’s Mulligan
By
Sy Mukherjee